Investigation Overview
October 21, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) was announced over potential breaches of fiduciary duties by certain officers and directors at Rigel Pharmaceuticals. The investigation by a law firm concerns whether certain Rigel Pharmaceuticals directors breached their fiduci...
You must register (for free) or login to view the entire investigation.